
CAS 1130067-18-3
:N-(2-{4-[2-oxo-2,3-dihydro-1H-benzo(d)iMidazol-1-yl]piperidin-1-yl}ethyl)-2-naphthaMide
Description:
N-(2-{4-[2-oxo-2,3-dihydro-1H-benzo(d)imidazol-1-yl]piperidin-1-yl}ethyl)-2-naphthamide is a complex organic compound characterized by its unique structural features, which include a naphthamide moiety and a piperidine ring substituted with a benzoimidazole. This compound is typically classified as a pharmaceutical intermediate or a potential drug candidate due to its intricate structure, which may contribute to biological activity. The presence of the benzoimidazole and piperidine components suggests potential interactions with biological targets, making it of interest in medicinal chemistry. The compound's solubility, stability, and reactivity would depend on its specific functional groups and overall molecular conformation. Additionally, its synthesis may involve multi-step organic reactions, highlighting the importance of careful handling and characterization in a laboratory setting. As with many compounds in drug development, understanding its pharmacokinetics and pharmacodynamics would be crucial for assessing its therapeutic potential.
Formula:C25H26N4O2
Synonyms:- N-(2-{4-[2-OXO-2,3-DIHYDRO-1H-BENZO(D)IMIDAZOL-1-YL]PIPERIDIN-1-YL}ETHYL)-2-NAPHTHAMIDE;VU0155056
- N-(2-{4-[2-oxo-2,3-dihydro-1H-benzo(d)iMidazol-1-yl]piperidin-1-yl}ethyl)-2-naphthaMide
- VU0155056
- 2-Naphthalenecarboxamide, N-[2-[4-(2,3-dihydro-2-oxo-1H-benzimidazol-1-yl)-1-piperidinyl]ethyl]-
Sort by
Purity (%)
0
100
|
0
|
50
|
90
|
95
|
100
Found 2 products.
VU0155056
CAS:<p>VU0155056 is a dual PLD1/2 inhibitor with IC50 < 1 µM in cellular assays, inhibits breast cancer cell invasion.</p>Formula:C25H26N4O2Purity:98.6% - 99.15%Color and Shape:SolidMolecular weight:414.5


